Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 3, 2011, Pages 248-252

  Friedrich, David ^a   Jalbert, Emilie ^a,e   Dinges, Warren L ^a,b   Sidney, John ^c   Sette, Alex ^c   Huang, Yunda ^a   McElrath, M Juliana ^a,b,c   Horton, Helen ^a,b,d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV vaccine; immunodominance; preferential HLA usage

Indexed keywords

HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RECOMBINANT VACCINE; T LYMPHOCYTE RECEPTOR;

ALLELE; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AIDS VACCINES; ALLELES; EPITOPES, T-LYMPHOCYTE; HIV-1; HLA ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; VACCINES, SYNTHETIC;

EID: 80054921082     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318228f992     Document Type: Article

References (20)

1. Buchbinder SP, Hehrotra DV, Duerr A, et al. Efficacy assessment of a cellmediated immunity HIV-1 vaccine (the Step Study): a double-blinded, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372: 1881-1893.
2. Wilson NA, Keele BF, Reed JS, et al. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol. 2009;83:6508-6521.
3. Hansen SG, Vieville C, Whizin N, et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med. 2009;15:293-299.
4. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol. 1999;17:51-88. (Pubitemid 29241119)
5. Tenzer S, Wee E, Burgevin A, et al. Antigen processing influences HIVspecific cytotoxic T lymphocyte immunodominance. Nat Immunol. 2009; 10:636-646.
6. Kotturi MF, Scott I, Wolfe T, et al. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol. 2008;181:2124-2133.
7. Horton H, Frank I, Baydo R, et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol. 2006;177:7406-7415. (Pubitemid 44715111)
8. Dinges WL, Richardt J, Friedrich D, et al. Virus specific CD8+ T cell responses better define HIV disease progression than HLA genotype. J Virol. 2010;84:4461-4468.
9. Peiperl L, Morgan C, Moodie Z, et al. Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). PLoS ONE. 2010;5:e13579.
10. Nicholson O, Dicandilo F, Kublin J, et al. Safety and Immunogenicity of the MRKAd5 gag HIV-1 Vaccine in aWorldwide Phase 1 Study of healthy Adults. AIDS Res Hum Retroviruses. November 23, 2010. 2011;27: 557-567.
11. Li F, Malhotra U, Gilbert PB, et al. Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation. Vaccine. 2006;24 6893-6904. (Pubitemid 46107181)
12. Sidney J, Southwood S, Oseroff C, et al. Measurements of MHC/Peptide Interactions by Gel Filtration. Current Protocols in Immunology. New York, NY: Wiley; 1998:18.13.11-18.13.19.
13. Kaslow RA, Rivers C, Tang J, et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J Virology. 2001;75:8681-8689. (Pubitemid 32768972)
14. Goulder PJ, Altfeld MA, Rosenberg ES, et al. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med. 2001;193:181-194.
15. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med. 2001;344:1668-1675. (Pubitemid 32479964)
16. Koup RA, Roederer M, Lamoreaux L, et al. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. PLoS ONE. 2010;5: e9015.
17. Payne R, Kloverpris H, Sacha J, et al. Efficacious early antiviral activity of HIV Gag-and Pol-specific HLA-B*2705-restricted CD8+ T-cells. J Virology. 2010;84:10543-10557.
18. Lichterfeld M, Yu XG, Mui SK, et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol. 2007;81:4199-4214. (Pubitemid 46586914)
19. Chen W, Norbury CC, Cho Y, et al. Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med. 2001; 193:1319-1326. (Pubitemid 32524782)
20. Thirdborough SM, Roddick JS, Radcliffe JN, et al. Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class I complexes. Eur J Immunol. 2008;38:364-369.